Laszlo George Radvanyi

University Of Tx Md Anderson Can Ctr

$2,629,361

Attributed

$2,807,271

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $592.8K · FY2006–14

$1M$750K$500K$250K$0

'06

'07

'08

'09

'10

'11

'12

'13

'14

Funding mix

By agency

NIH$2,807,271 · 5

By mechanism

P01$1,629,646 · 1

P30$499,979 · 1

R01$355,821 · 1

R21$174,000 · 1

R03$147,825 · 1

Top collaborators

Patrick Hwu1 shared

Most similar at University Of Tx Md Anderson Can Ctr

Same institution · by research overlap

Michael Davies$11,575,720
Sattva S Neelapu$3,334,171
Michael W Andreeff$17,991,896
David Z Chang$136,080
Gregory A Lizee$3,884,952

Others in their field

Top investigators on “Malignant Neoplasms”

David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
Richard K. Wilson · Washington University$274,272,747
Larry Arthur$223,443,122
Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879

Research focus

Malignant NeoplasmsT-LymphocyteProgramsImmunotherapyTechnologyPhenotypeCancer PatientClinical TrialsAntigensCell Mediated Immune ResponseCancer TherapyPeptidesCancer CenterImmune ResponseFutureNeoplastic CellB-LymphocytesCytokineEnzyme Linked Immunospot AssayCell PhysiologyImmuneMonitorAreaCollaborations